RECRUITING

Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objective of the proposed project is to quantify the prevalence and disparities of undiagnosed left ventricular hypertrophy (LVH) in Emergency Department (ED) patients with persistently elevated asymptomatic BP, and to measure the effect of disclosure, education, and expedited referral on 3-month outpatient follow-up and treatment rates for ED patients with newly diagnosed LVH by POCUS. Additionally, investigators will create a database of annotated clips for future development of a machine learning algorithm for LVH detection on POCUS.

Official Title

Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy

Quick Facts

Study Start:2023-10-15
Study Completion:2025-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05730309

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Two blood pressure measurements greater than 140 mmHg systolic and greater than 90 mmHg diastolic on two separate vital sign checks obtained as part of routine ED care
  1. * Subjects in extremis or lacking capacity to consent
  2. * Active treatment of hypertension within the last year
  3. * History of/known left ventricular hypertrophy
  4. * Active cardiac disease under the care of a cardiologist within last year
  5. * Suspicion for hypertensive emergency by treating ED physician
  6. * Admission to the hospital

Contacts and Locations

Study Contact

Cristiana Baloescu, MD, MPH
CONTACT
(203) 737-2644
cristiana.baloescu@yale.edu

Study Locations (Sites)

Yale New Haven Hospital
New Haven, Connecticut, 06512
United States

Collaborators and Investigators

Sponsor: Yale University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-15
Study Completion Date2025-08

Study Record Updates

Study Start Date2023-10-15
Study Completion Date2025-08

Terms related to this study

Additional Relevant MeSH Terms

  • Left Ventricular Hypertrophy